Propranolol for Challenging Behaviors in Autism

PHASE2CompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

February 11, 2021

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Autism Spectrum DisorderDevelopmental DisabilityAggressionSelf-Injurious BehaviorChallenging Behavior
Interventions
DRUG

Propranolol

Propranolol is a beta-blocker used to treat high blood pressure, irregular heartbeats, and tremors. It is used after a heart attack and to prevent migraine headaches and chest pain. It is also used off-label for anxiety and PTSD.

Trial Locations (1)

08901

Department of Pediatrics, Division of Pediatric Neurology, Robert Wood Johnson Medical School, New Brunswick

All Listed Sponsors
collaborator

New Jersey Governor's Council for Medical Research and Treatment of Autism

UNKNOWN

collaborator

New York State Institute for Basic Research

OTHER_GOV

lead

Rutgers, The State University of New Jersey

OTHER

NCT04047355 - Propranolol for Challenging Behaviors in Autism | Biotech Hunter | Biotech Hunter